Abstract
The present work reports the effect of conjugation of the anticarcinogenic and antitumor soybean Bowman-Birk protease inhibitor (BBI) with amphiphilic block copolymer of ethylene oxide and propylene oxide (PEO-PPO) as well as with monoclonal antibody via clinical dextran (D) on tumor-targeted delivery of BBI.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 303-308 |
| Number of pages | 6 |
| Journal | Journal of Controlled Release |
| Volume | 74 |
| Issue number | 1-3 |
| DOIs | |
| State | Published - Jul 6 2001 |
| Externally published | Yes |
Keywords
- Ethylene oxide and propylene oxide block copolymer
- Immunoconjugate
- Soybean Bowman-Birk protease inhibitor (BBI)
- Targeting
- Tumor
ASJC Scopus subject areas
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS